The company I work for Revalesio. Is currently participating in a fundraiser for the American Heart Association. Revalesio is a clinical-stage pharmaceutical company committed to developing treatments for stroke and age-related neurological disorders that lack adequate therapeutic options. Our lead drug candidate, RNS60, has the potential to help people recover from an ischemic stroke. Which is the #1 cause of disability and #2 cause of death worldwide.

This fundraiser also carries personal significance with both of my Grandparents passing from Heart or Stroke related reasons.

Thank you for taking to the time to read this and please consider donating if able.

Dillon